Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (31-40 of 420) with videos related to

Pageof 42
Sort By:
Current Opinion in Hematology|January 17, 2015
Is it time to change conventional consolidation chemotherapy for acute myeloid leukemia in CR1?Ofir Wolach, Richard M Stone
Expert Review of Hematology|December 22, 2017
A concise review of BCL-2 inhibition in acute myeloid leukemiaMeera Yogarajah, Richard M Stone
Acta Haematologica|November 30, 2023
Untangling Complexities of Acute Myeloid Leukemia Review SeriesShai Shimony, Richard M Stone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2015
Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic LeukemiaOfir Wolach, Richard M Stone
Current Opinion in Hematology|January 19, 2017
Mixed-phenotype acute leukemia: current challenges in diagnosis and therapyOfir Wolach, Richard M Stone
Current Treatment Options in Oncology|September 9, 2011
Treatment of elderly acute myeloid leukemia patientsGabriela Motyckova, Richard M Stone
Blood Advances|May 21, 2026
HMA + venetoclax triplet regimens for the initial treatment of AML in adults- CONTRAMaximilian Stahl, Richard M Stone
Gynecologic Oncology|November 3, 2018
The impact of new drugs for breast and ovarian cancer on the occurrence of therapy-related myeloid neoplasms: Understanding the baseline incidenceTal Sella, Richard M Stone
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
The role of myeloid growth factors in acute leukemiaMartha Wadleigh, Richard M Stone
Current Hematologic Malignancy Reports|April 29, 2010
Lenalidomide in myelodysplastic syndromes: where do we go from here?L Andres Sirulnik, Richard M Stone
Pageof 42

Showing results (31-40 of 420) with videos related to

Sort By:
Pageof 42
Current Opinion in Hematology|January 17, 2015
Is it time to change conventional consolidation chemotherapy for acute myeloid leukemia in CR1?Ofir Wolach, Richard M Stone
Expert Review of Hematology|December 22, 2017
A concise review of BCL-2 inhibition in acute myeloid leukemiaMeera Yogarajah, Richard M Stone
Acta Haematologica|November 30, 2023
Untangling Complexities of Acute Myeloid Leukemia Review SeriesShai Shimony, Richard M Stone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2015
Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic LeukemiaOfir Wolach, Richard M Stone
Current Opinion in Hematology|January 19, 2017
Mixed-phenotype acute leukemia: current challenges in diagnosis and therapyOfir Wolach, Richard M Stone
Current Treatment Options in Oncology|September 9, 2011
Treatment of elderly acute myeloid leukemia patientsGabriela Motyckova, Richard M Stone
Blood Advances|May 21, 2026
HMA + venetoclax triplet regimens for the initial treatment of AML in adults- CONTRAMaximilian Stahl, Richard M Stone
Gynecologic Oncology|November 3, 2018
The impact of new drugs for breast and ovarian cancer on the occurrence of therapy-related myeloid neoplasms: Understanding the baseline incidenceTal Sella, Richard M Stone
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
The role of myeloid growth factors in acute leukemiaMartha Wadleigh, Richard M Stone
Current Hematologic Malignancy Reports|April 29, 2010
Lenalidomide in myelodysplastic syndromes: where do we go from here?L Andres Sirulnik, Richard M Stone
Pageof 42